Skip to main content
Top
Published in: World Journal of Surgery 2/2018

01-02-2018 | Original Scientific Report

Papillary Thyroid Carcinoma (PTC) in Children and Adults: Comparison of Initial Presentation and Long-Term Postoperative Outcome in 4432 Patients Consecutively Treated at the Mayo Clinic During Eight Decades (1936–2015)

Authors: Ian D. Hay, Tammi R. Johnson, Suneetha Kaggal, Megan S. Reinalda, Nicole M. Iniguez-Ariza, Clive S. Grant, Siobhan T. Pittock, Geoffrey B. Thompson

Published in: World Journal of Surgery | Issue 2/2018

Login to get access

Abstract

Background

Contemporary guidelines for managing PTC advise an approach wherein primary tumor and regional metastases (RM) are completely resected at first surgery and radioiodine remnant ablation (RRA) is restricted to high-risk patients, policies our group has long endorsed. To assess our therapeutic efficacy, we studied 190 children and 4242 adults consecutively treated during 1936–2015.

Subjects and methods

Mean follow-up durations for children and adults were 26.9 and 15.2 years, respectively. Bilateral lobar resection was performed in 86% of children and 88% of adults, followed by RRA in 30% of children and 29% of adults; neck nodes were excised in 86% of children and 66% of adults. Tumor recurrence (TR) and cause-specific mortality (CSM) details were taken from a computerized database.

Results

Children, when compared to adults, had larger primary tumors which more often were grossly invasive and incompletely resected. At presentation, children, as compared to adults, had more RM and distant metastases (DM). Thirty-year TR rates were no different in children than adults at any site. Thirty-year CSM rates were lower in children than adults (1.1 vs. 4.9%; p = 0.01). Comparing 1936–1975 (THEN) with 1976–2015 (NOW), 30-year CSM rates were similar in MACIS <6 children (p = 0.67) and adults (p = 0.08). However, MACIS <6 children and adults in 1976–2015 had significantly higher recurrence at local and regional, but not at distant, sites. MACIS 6+ adults, NOW, compared to THEN, had lower 30-year CSM rates (30 vs. 47%; p < 0.001), unassociated with decreased TR at any site.

Conclusions

Children, despite presenting with more extensive PTC when compared to adults, have postoperative recurrences at similar frequency, typically coexist with DM and die of PTC less often. Since 1976, both children and adults with MACIS <6 PTC have a <1% chance at 30 years of CSM; adults with higher MACIS scores (6 or more) have a 30-year CSM rate of 30%.
Literature
1.
go back to reference Sitges-Serra A (2014) Low-risk papillary thyroid cancer: times are changing. Expert Rev Endocrinol Metab 9(1):9–18CrossRef Sitges-Serra A (2014) Low-risk papillary thyroid cancer: times are changing. Expert Rev Endocrinol Metab 9(1):9–18CrossRef
2.
go back to reference Davies L, Morris LG, Haymart M et al (2015) AACE and ACE disease state clinical review: the increasing incidence of thyroid cancer. Endocr Pract 21(6):686–696CrossRefPubMedPubMedCentral Davies L, Morris LG, Haymart M et al (2015) AACE and ACE disease state clinical review: the increasing incidence of thyroid cancer. Endocr Pract 21(6):686–696CrossRefPubMedPubMedCentral
3.
go back to reference Vaccarella S, Franceschi S, Bray F et al (2016) Worldwide thyroid cancer epidemic? The increasing impact of overdiagnosis. N Engl J Med 375(7):614–617CrossRefPubMed Vaccarella S, Franceschi S, Bray F et al (2016) Worldwide thyroid cancer epidemic? The increasing impact of overdiagnosis. N Engl J Med 375(7):614–617CrossRefPubMed
4.
go back to reference Nixon IJ, Shah JP (2014) Well differentiated thyroid cancer: are we over treating our patients? EJSO 40:129–132CrossRefPubMed Nixon IJ, Shah JP (2014) Well differentiated thyroid cancer: are we over treating our patients? EJSO 40:129–132CrossRefPubMed
5.
go back to reference Hay ID, McConahey WM, Goellner JR (2002) Managing patients with papillary thyroid carcinoma: insights gained from the Mayo Clinic’s experience of treating 2,512 consecutive patients during 1940 through 2000. Trans Am Clin Climatol Assoc 113:241–260PubMedPubMedCentral Hay ID, McConahey WM, Goellner JR (2002) Managing patients with papillary thyroid carcinoma: insights gained from the Mayo Clinic’s experience of treating 2,512 consecutive patients during 1940 through 2000. Trans Am Clin Climatol Assoc 113:241–260PubMedPubMedCentral
6.
go back to reference Nixon IJ, Ganly I, Patel SG et al (2012) Changing trends in well differentiated thyroid carcinoma over eight decades. Int J Surg 10(10):618–623CrossRefPubMed Nixon IJ, Ganly I, Patel SG et al (2012) Changing trends in well differentiated thyroid carcinoma over eight decades. Int J Surg 10(10):618–623CrossRefPubMed
7.
go back to reference Kiernan CM, Whiteside MA, Solorzano CC (2017) Cancer registries: can we improve the quality of thyroid cancer data? Ann Surg Oncol 24(5):1202–1207CrossRefPubMed Kiernan CM, Whiteside MA, Solorzano CC (2017) Cancer registries: can we improve the quality of thyroid cancer data? Ann Surg Oncol 24(5):1202–1207CrossRefPubMed
8.
go back to reference Grant CS, Stulak JM, Thompson GB et al (2010) Risks and adequacy of an optimized surgical approach to the primary surgical management of papillary thyroid carcinoma treated during 1999–2006. World J Surg 34(6):1239–1246. doi:10.1007/s00268-009-0307-9 CrossRefPubMed Grant CS, Stulak JM, Thompson GB et al (2010) Risks and adequacy of an optimized surgical approach to the primary surgical management of papillary thyroid carcinoma treated during 1999–2006. World J Surg 34(6):1239–1246. doi:10.​1007/​s00268-009-0307-9 CrossRefPubMed
10.
go back to reference Zimmerman D, Hay ID, Gough IR et al (1988) Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients treated at one institution during three decades. Surgery 104:1157–1166PubMed Zimmerman D, Hay ID, Gough IR et al (1988) Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients treated at one institution during three decades. Surgery 104:1157–1166PubMed
11.
12.
go back to reference McConahey WM, Hay ID, Woolner LB et al (1986) Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy and outcome. Mayo Clin Proc 61:978–996CrossRefPubMed McConahey WM, Hay ID, Woolner LB et al (1986) Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy and outcome. Mayo Clin Proc 61:978–996CrossRefPubMed
13.
go back to reference Hay ID (1990) Papillary thyroid carcinoma. Endo Metab Clin N Am 19(3):545–576 Hay ID (1990) Papillary thyroid carcinoma. Endo Metab Clin N Am 19(3):545–576
14.
go back to reference Hay ID, Thompson GB, Grant CS et al (2002) Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940–1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 26:879–885. doi:10.1007/s00268-002-6612-1 CrossRefPubMed Hay ID, Thompson GB, Grant CS et al (2002) Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940–1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 26:879–885. doi:10.​1007/​s00268-002-6612-1 CrossRefPubMed
15.
go back to reference Hay ID, Bergstralh EJ, Goellner JR et al (1993) Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1,779 patients surgically treated at one institution during 1940 through 1990. Surgery 114:1050–1058PubMed Hay ID, Bergstralh EJ, Goellner JR et al (1993) Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1,779 patients surgically treated at one institution during 1940 through 1990. Surgery 114:1050–1058PubMed
16.
go back to reference Hay ID (2007) Management of patients with low-risk papillary thyroid carcinoma. Endocr Pract 13(3):521–533CrossRefPubMed Hay ID (2007) Management of patients with low-risk papillary thyroid carcinoma. Endocr Pract 13(3):521–533CrossRefPubMed
17.
go back to reference Francis GL, Waguespack SG, Bauer AJ et al (2015) Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid 25(7):716–759CrossRefPubMedPubMedCentral Francis GL, Waguespack SG, Bauer AJ et al (2015) Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid 25(7):716–759CrossRefPubMedPubMedCentral
18.
go back to reference Haugen BR (2017) 2015 ATA management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer; what is new and what has changed? Cancer 123(3):372–381CrossRefPubMed Haugen BR (2017) 2015 ATA management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer; what is new and what has changed? Cancer 123(3):372–381CrossRefPubMed
19.
go back to reference Hay ID (2006) Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma. J Surg Oncol 94(8):692–700CrossRefPubMed Hay ID (2006) Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma. J Surg Oncol 94(8):692–700CrossRefPubMed
20.
go back to reference Edge SB, Byrd DR, Compton CC et al (2010) AJCC cancer staging manual, 7th edn. Springer, New York, pp 67–74 Edge SB, Byrd DR, Compton CC et al (2010) AJCC cancer staging manual, 7th edn. Springer, New York, pp 67–74
21.
go back to reference Hay ID, Johnson TR, Thompson GB et al (2016) Minimal extrathyroidal extension in papillary thyroid carcinoma does not result in increased rates of either cause-specific mortality or postoperative tumor recurrence. Surgery 159(1):11–19CrossRefPubMed Hay ID, Johnson TR, Thompson GB et al (2016) Minimal extrathyroidal extension in papillary thyroid carcinoma does not result in increased rates of either cause-specific mortality or postoperative tumor recurrence. Surgery 159(1):11–19CrossRefPubMed
22.
go back to reference LiVolsi VA, Albores-Saavedra J, Asa SL (2004) Papillary thyroid carcinoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) Pathology and genetics of tumours of endocrine organs: WHO classification of tumours. IARC Press, Lyon, pp 57–66 LiVolsi VA, Albores-Saavedra J, Asa SL (2004) Papillary thyroid carcinoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) Pathology and genetics of tumours of endocrine organs: WHO classification of tumours. IARC Press, Lyon, pp 57–66
24.
go back to reference Carhill AA, Litofsky DR, Ross DS et al (2015) Long-term outcomes following therapy in differentiated thyroid carcinoma: NTCTCS registry analysis 1987–2012. J Clin Endocrinol Metab 100:3270–3279CrossRefPubMedPubMedCentral Carhill AA, Litofsky DR, Ross DS et al (2015) Long-term outcomes following therapy in differentiated thyroid carcinoma: NTCTCS registry analysis 1987–2012. J Clin Endocrinol Metab 100:3270–3279CrossRefPubMedPubMedCentral
25.
go back to reference Hay ID, Grant CS, Taylor WF et al (1987) Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 102:1088–1094PubMed Hay ID, Grant CS, Taylor WF et al (1987) Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 102:1088–1094PubMed
26.
go back to reference Cady B (1997) Our AMES is true: how an old concept still hits the mark: or, risk group assignment points the arrow to rational therapy selection in differentiated thyroid cancer. Am J Surg 197:462–468CrossRef Cady B (1997) Our AMES is true: how an old concept still hits the mark: or, risk group assignment points the arrow to rational therapy selection in differentiated thyroid cancer. Am J Surg 197:462–468CrossRef
27.
go back to reference Cady B (1998) Papillary carcinoma of the thyroid gland: treatment based on risk group definition. Surg Clin N Am 7:633–644 Cady B (1998) Papillary carcinoma of the thyroid gland: treatment based on risk group definition. Surg Clin N Am 7:633–644
28.
go back to reference Pemberton JJ (1928) Malignant disease of the thyroid gland: a clinical consideration. Ann Surg 87:369–377CrossRef Pemberton JJ (1928) Malignant disease of the thyroid gland: a clinical consideration. Ann Surg 87:369–377CrossRef
29.
go back to reference Mazzaferri EL, Young RL, Oertel JE et al (1977) Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine (Baltimore) 56:171–196CrossRef Mazzaferri EL, Young RL, Oertel JE et al (1977) Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine (Baltimore) 56:171–196CrossRef
30.
go back to reference Lubitz CC, Kong CY, McMahon PM et al (2014) Annual financial impact of well-differentiated thyroid cancer care in the United States. Cancer 120:1345–1352CrossRefPubMedPubMedCentral Lubitz CC, Kong CY, McMahon PM et al (2014) Annual financial impact of well-differentiated thyroid cancer care in the United States. Cancer 120:1345–1352CrossRefPubMedPubMedCentral
31.
32.
go back to reference Cady B (1978) Basic principles in surgical oncology. Presidential address. Arch Surgery 132:338–346CrossRef Cady B (1978) Basic principles in surgical oncology. Presidential address. Arch Surgery 132:338–346CrossRef
34.
go back to reference Lubitz CC, Sosa JA (2016) The changing landscape of papillary thyroid cancer: epidemiology, management, and the implications for patients. Cancer 122:3754–3759CrossRefPubMed Lubitz CC, Sosa JA (2016) The changing landscape of papillary thyroid cancer: epidemiology, management, and the implications for patients. Cancer 122:3754–3759CrossRefPubMed
35.
go back to reference Dominguez JM, Nilo F, Contreras T et al (2017) Neck sonography and suppressed thyroglobulin have high sensitivity for identifying persistent/recurrent disease with low-risk thyroid cancer treated with total thyroidectomy and radioactive iodine ablation, making stimulated thyroglobulin unnecessary. J Ultrasound Med. doi:10.1002/jum.14260 (Epub ahead of print) PubMed Dominguez JM, Nilo F, Contreras T et al (2017) Neck sonography and suppressed thyroglobulin have high sensitivity for identifying persistent/recurrent disease with low-risk thyroid cancer treated with total thyroidectomy and radioactive iodine ablation, making stimulated thyroglobulin unnecessary. J Ultrasound Med. doi:10.​1002/​jum.​14260 (Epub ahead of print) PubMed
Metadata
Title
Papillary Thyroid Carcinoma (PTC) in Children and Adults: Comparison of Initial Presentation and Long-Term Postoperative Outcome in 4432 Patients Consecutively Treated at the Mayo Clinic During Eight Decades (1936–2015)
Authors
Ian D. Hay
Tammi R. Johnson
Suneetha Kaggal
Megan S. Reinalda
Nicole M. Iniguez-Ariza
Clive S. Grant
Siobhan T. Pittock
Geoffrey B. Thompson
Publication date
01-02-2018
Publisher
Springer International Publishing
Published in
World Journal of Surgery / Issue 2/2018
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-017-4279-x

Other articles of this Issue 2/2018

World Journal of Surgery 2/2018 Go to the issue